Palmu, Arto A. I. MD, PhD*; Verho, Jouko MSc*; Jokinen, Jukka MSc*; Karma, Pekka MD, PhD†; Kilpi, Terhi M. MD, PhD*
From the *National Public Health Institute and †Helsinki University Hospital, Helsinki, Finland
Accepted for publication April 5, 2004.
The FinOM Vaccine Trial was supported by Merck & Co., Inc., Aventis Pasteur and Wyeth-Lederle Vaccines. The FinOM Follow-up Study was supported by Wyeth-Lederle Vaccines.
Reprints not available.
doi: 10.1097/01.inf.0000133049.30299.5d